Cantila, Felecidad L.
HRN: 25-78-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/11/2024
09/18/2024
IV
2.25g
Every 6 Hours
Unresolved UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes